Patents by Inventor David Driver

David Driver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10808027
    Abstract: Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: October 20, 2020
    Assignee: Eli Lilly and Company
    Inventors: Mansuo Lu Hayashi, Jirong Lu, David Driver, Alberto Alvarado
  • Patent number: 10309443
    Abstract: A multiple-hole rope thimble with a body, a plurality of holes, and a perimeter groove. The holes can be arranged linearly or non-linearly arranged and can be the same or different sizes. The hole wall is curved toward the center of the hole to eliminate any sharp edges that can damage a rope. The groove extends completely around the perimeter of the body. A rope fits into the groove and is secured around the thimble by a splice or a knot. Optionally, the rope is secured by a thread extending through an aperture in the partition between holes.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: June 4, 2019
    Assignee: ETCO, Inc.
    Inventor: J. David Driver
  • Publication number: 20180265577
    Abstract: Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
    Type: Application
    Filed: May 31, 2018
    Publication date: September 20, 2018
    Inventors: Mansuo Lu Hayashi, Jirong Lu, David Driver, Alberto Alvarado
  • Patent number: 10011653
    Abstract: Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: July 3, 2018
    Assignee: Eli Lilly and Company
    Inventors: Mansuo Lu Hayashi, Jirong Lu, David Driver, Alberto Alvarado
  • Publication number: 20170107278
    Abstract: Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
    Type: Application
    Filed: November 10, 2016
    Publication date: April 20, 2017
    Inventors: Mansuo Lu Hayashi, Jirong Lu, David Driver, Alberto Alvarado
  • Patent number: 9527909
    Abstract: Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: December 27, 2016
    Assignee: Eli Lilly and Company
    Inventors: Mansuo Lu Hayashi, Jirong Lu, David Driver, Alberto Alvarado
  • Publication number: 20160251420
    Abstract: Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
    Type: Application
    Filed: February 18, 2016
    Publication date: September 1, 2016
    Inventors: Mansuo Lu Hayashi, Jirong Lu, David Driver, Alberto Alvarado
  • Publication number: 20150044666
    Abstract: Methods and kits related to non-equilibrium, ultrasensitive two-site assays for detecting analytes are provided. In one aspect, a two-site assays for detecting analytes under non-equilibrium analyte binding conditions, using low concentrations of reporter specificity molecule (e.g., reporter antibody) and kits for performing the same is provided. In another aspect, methods for selecting antibodies or specificity molecules with low dissociation constants for use as reporter antibodies in non-equilibrium two-site immunoassays, including two-site immuno-PCR assays, and assays performed with those antibodies, are also provided.
    Type: Application
    Filed: January 11, 2013
    Publication date: February 12, 2015
    Inventors: Edward Jablonski, Thomas H. Adams, David Driver, Thomas Brendan Ryder
  • Patent number: 8647864
    Abstract: Compositions and methods are provided for Eukaryotic Layered Vector Initiation Systems and Alphavirus replicon particles for introducing heterologous sequences into cells for generating immune responses.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: February 11, 2014
    Assignee: Novartis AG
    Inventors: John M Polo, Thomas W Dubensky, Jr., Ilya Frolov, Jason P Gardner, Gillis Otten, Susan Barnett, David A Driver
  • Patent number: 7977091
    Abstract: The present disclosure provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Grant
    Filed: August 10, 2009
    Date of Patent: July 12, 2011
    Assignee: Novartis Vaccines & Diagnostics, Inc.
    Inventors: Thomas W. Dubensky, Jr., John M Polo, Carlos E Ibanez, Stephen M. W. Chang, Douglas J Jolly, David A Driver, Barbara A Belli
  • Publication number: 20100266631
    Abstract: Compositions and methods are provided for Eukaryotic Layered Vector Initiation Systems and Alphavirus replicon particles for introducing heterologous sequences into cells for generating immune responses.
    Type: Application
    Filed: June 29, 2010
    Publication date: October 21, 2010
    Applicant: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
    Inventors: John Polo, Thomas W. Dubensky, JR., Ilya Frolov, Jason P. Gardner, Gillis Otten, Susan Barnett, David A. Driver
  • Patent number: 7771979
    Abstract: Methods are provided for generating immune responses utilizing alphavirus-based vector systems.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: August 10, 2010
    Assignee: Novartis Vaccines & Diagnostics, Inc.
    Inventors: John Polo, Thomas W. Dubensky, Jr., Ilya Frolov, Jason P. Gardner, Gillis Otten, Susan Barnett, David A. Driver
  • Publication number: 20100173412
    Abstract: The present disclosure provides compositions and methods for utilizing recombinant alphavirus vectors.
    Type: Application
    Filed: August 10, 2009
    Publication date: July 8, 2010
    Inventors: Thomas W. Dubensky, JR., John M. Polo, Carlos E. Ibanez, Stephen M.W. Chang, Douglas J. Jolly, David A. Driver, Barbara A. Belli
  • Patent number: 7572628
    Abstract: The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: August 11, 2009
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Thomas W. Dubensky, Jr., John M. Polo, Carlos E. Ibanez, Stephen M. W. Chang, Douglas J. Jolly, David A. Driver, Barbara A. Belli
  • Publication number: 20080226598
    Abstract: Methods are provided for generating immune responses utilizing alphavirus-based vector systems.
    Type: Application
    Filed: February 27, 2007
    Publication date: September 18, 2008
    Inventors: John Polo, Thomas W. Dubensky, Ilya Frolov, Jason P. Gardner, Gillis Otten, Susan Barnett, David A. Driver
  • Publication number: 20070118841
    Abstract: Allowing queue messages to be pulled by one or more applications. A method may be practiced, for example, in a computing environment including applications configured to receive messages from queues. The method includes correlating applications to queues by correlating queue names to application locations. A queue is monitored to discover new messages in the queue. The method further includes receiving a notification that a new message has been added to the queue. An indication is provided to an activation service to allow the activation service to activate an application correlated to the queue and to allow the application to pull the new message from the queue.
    Type: Application
    Filed: November 22, 2005
    Publication date: May 24, 2007
    Inventors: David Driver, Geoffrey Kizer, Krishnan Srinivasan, Uday Hedge
  • Publication number: 20060168023
    Abstract: The present invention extends to methods, systems, and computer program products for reliably and securely transferring queued application messages. Application messages are (e.g.,. binary or text) encoded and then encapsulated in transfer messages, enqueue messages, and dequeue responses such that composable protocol elements used in application messages can be reused in the transfer messages, enqueue messages, and dequeue responses. Transfer message headers are encoded and then encapsulated along with encoded application messages such that composable protocol elements used in transfer headers and application messages can be reused in the store and forward messages. Application messages, transfer messages, enqueue messages, dequeue responses, and store and forward messages can all be configured in accordance with the same messaging protocol, such as, for example, Simple Object Access Protocol.
    Type: Application
    Filed: December 10, 2004
    Publication date: July 27, 2006
    Applicant: Microsoft Corporation
    Inventors: Krishnan Srinivasan, Craig Critchley, Uday Hegde, Alan Geller, David Driver, Richard Hill, Rodney Limprecht
  • Publication number: 20060168052
    Abstract: The present invention extends to methods, systems, and computer program products for reliably and securely transferring queued application messages. Application messages are (e.g., binary or text) encoded and then encapsulated in transfer messages, enqueue messages, and dequeue responses such that composable protocol elements used in application messages can be reused in the transfer messages, enqueue messages, and dequeue responses. Transfer message headers are encoded and then encapsulated along with encoded application messages such that composable protocol elements used in transfer headers and application messages can be reused in the store and forward messages. Application messages, transfer messages, enqueue messages, dequeue responses, and store and forward messages can all be configured in accordance with the same messaging protocol, such as, for example, Simple Object Access Protocol.
    Type: Application
    Filed: June 23, 2005
    Publication date: July 27, 2006
    Applicant: Microsoft Corporation
    Inventors: Krishnan Srinivasan, Craig Critchley, Uday Hegde, Alan Geller, David Driver, Richard Hill, Rodney Limprecht
  • Publication number: 20060150200
    Abstract: A web services namespace pertains to an infrastructure for enabling creation of a wide variety of applications. The infrastructure provides a foundation for building message-based applications of various scale and complexity. The infrastructure or framework provides APIs for basic messaging, secure messaging, reliable messaging and transacted messaging. In some embodiments, the associated APIs are factored into a hierarchy of namespaces in a manner that balances utility, usability, extensibility and versionability.
    Type: Application
    Filed: December 3, 2004
    Publication date: July 6, 2006
    Applicant: Microsoft Corporation
    Inventors: Shy Cohen, Geary Eppley, Douglas Purdy, James Johnson, Stephen Millet, Stephen Swartz, Vijay Gajjala, Aaron Stern, Alexander DeJarnatt, Alfred Lee, Anand Rjagopalan, Anastasios Kasiolas, Chaitanya Upadhyay, Christopher Kaler, Craig Critchley, David Levin, David Driver, David Wortendyke, Douglas Walter, Elliot Waingold, Erik Christensen, Erin Honeycutt, Eugene Shvets, Evgeny Osovetsky, Giovanni Della-Libera, Jesus Ruiz-Scougall, John Doty, Jonathan Wheeler, Kapil Gupta, Kenneth Wolf, Krishnan Srinivasan, Lance Olson, Matthew Tavis, Mauro Ottaviani, Max Feingold, Michael Coulson, Michael Marucheck, Michael Vernal, Michael Dice, Mohamed-Hany Ramadan, Mohammad Makarechian, Natasha Jethanandani, Richard Dievendorff, Richard Hill, Ryan Sturgell, Saurab Nog, Scott Seely, Serge Sverdlov, Siddhartha Puri, Sowmyanarayanan Srinivasan, Stefan Batres, Stefan Pharies, Tirunelveli Vishwanath, Tomasz Janczuk, Uday Hegde, Umesh Madan, Vaithialingam Balayogan, Vipul Modi, Yaniv Pessach, Yasser Shohoud
  • Publication number: 20060130069
    Abstract: The present invention extends to methods, systems, and computer program products for reliably and securely transferring queued application messages. Application messages are (e.g.,. binary or text) encoded and then encapsulated in transfer messages, enqueue messages, and dequeue responses such that composable protocol elements used in application messages can be reused in the transfer messages, enqueue messages, and dequeue responses. Transfer message headers are encoded and then encapsulated along with encoded application messages such that composable protocol elements used in transfer headers and application messages can be reused in the store and forward messages. Application messages, transfer messages, enqueue messages, dequeue responses, and store and forward messages can all be configured in accordance with the same messaging protocol, such as, for example, Simple Object Access Protocol.
    Type: Application
    Filed: June 23, 2005
    Publication date: June 15, 2006
    Applicant: Microsoft Corporation
    Inventors: Krishnan Srinivasan, Craig Critchley, Uday Hegde, Alan Geller, David Driver, Richard Hill, Rodney Limprecht